tiprankstipranks
Trending News
More News >
PHC Holdings Corp. (JP:6523)
:6523
Advertisement

PHC Holdings Corp. (6523) AI Stock Analysis

Compare
0 Followers

Top Page

JP:6523

PHC Holdings Corp.

(Frankfurt:6523)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
¥993.00
▲(2.58% Upside)
PHC Holdings Corp. has a moderate overall stock score of 54. The company's financial performance is challenged by declining revenue and high leverage, which are significant risk factors. However, the stock's valuation is attractive with a low P/E ratio and a high dividend yield, providing potential upside. Technical indicators suggest a bearish trend, but the oversold condition could lead to a rebound.

PHC Holdings Corp. (6523) vs. iShares MSCI Japan ETF (EWJ)

PHC Holdings Corp. Business Overview & Revenue Model

Company DescriptionPHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyPHC Holdings Corp. generates revenue through the sale of its wide array of healthcare products and services. Key revenue streams include the direct sale of medical devices and diagnostic equipment to hospitals, clinics, and laboratories, as well as providing maintenance, support, and training services associated with these products. The company also benefits from strategic partnerships and collaborations with other healthcare and technology firms, which enhance its product offerings and market reach. Additionally, PHC Holdings may engage in research and development activities, leading to the creation of innovative products that meet emerging healthcare needs, thereby contributing to its earnings. While specific financial details and partnerships are not disclosed in this context, the company's diversified portfolio and global presence are significant factors in its revenue generation.

PHC Holdings Corp. Financial Statement Overview

Summary
PHC Holdings Corp. faces challenges with declining revenue and profitability pressures, as evidenced by the negative revenue growth and low net profit margin. The balance sheet shows high leverage, which could be a risk factor, but the company maintains a moderate return on equity. Cash flow generation is improving, providing some financial flexibility. The company needs to focus on revenue growth and debt management to enhance its financial health.
Income Statement
45
Neutral
PHC Holdings Corp. has shown a decline in revenue with a negative growth rate of -36.8% in the TTM period, indicating significant challenges in maintaining sales momentum. The gross profit margin stands at 45.97%, which is relatively healthy, but the net profit margin is low at 2.90%, reflecting limited profitability. The EBIT and EBITDA margins are moderate at 6.68% and 14.39%, respectively, suggesting some operational efficiency but room for improvement.
Balance Sheet
50
Neutral
The company's debt-to-equity ratio is high at 1.80, indicating a significant reliance on debt financing, which could pose financial risks. Return on equity is modest at 7.45%, showing moderate efficiency in generating returns from equity. The equity ratio is approximately 26.54%, suggesting a balanced but slightly leveraged capital structure.
Cash Flow
55
Neutral
PHC Holdings Corp. has demonstrated a positive free cash flow growth rate of 5.07% in the TTM period, indicating improved cash generation. The operating cash flow to net income ratio is 0.30, and the free cash flow to net income ratio is 0.72, reflecting a reasonable conversion of income into cash flow, though there is room for strengthening cash flow efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue360.26B361.59B353.90B356.43B340.45B306.07B
Gross Profit166.85B166.22B157.97B169.13B165.24B143.65B
EBITDA53.17B52.33B30.15B36.76B37.56B62.29B
Net Income11.32B10.48B-12.89B-3.22B-8.46B16.91B
Balance Sheet
Total Assets519.78B532.48B564.33B561.57B591.32B569.02B
Cash, Cash Equivalents and Short-Term Investments34.83B39.59B51.82B63.25B97.63B63.96B
Total Debt251.40B255.26B285.05B292.62B307.94B321.55B
Total Liabilities382.48B391.31B425.16B422.74B455.26B461.46B
Stockholders Equity137.90B141.64B139.51B138.01B135.37B107.02B
Cash Flow
Free Cash Flow31.87B30.33B26.67B9.86B39.32B35.70B
Operating Cash Flow42.11B41.94B41.30B21.38B51.05B47.85B
Investing Cash Flow-7.30B-8.47B-21.07B-17.52B-12.52B-16.31B
Financing Cash Flow-37.22B-39.07B-39.14B-40.83B-7.01B-20.39B

PHC Holdings Corp. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price968.00
Price Trends
50DMA
979.25
Negative
100DMA
938.56
Positive
200DMA
951.91
Positive
Market Momentum
MACD
-8.33
Positive
RSI
44.40
Neutral
STOCH
15.96
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6523, the sentiment is Neutral. The current price of 968 is below the 20-day moving average (MA) of 997.78, below the 50-day MA of 979.25, and above the 200-day MA of 951.91, indicating a neutral trend. The MACD of -8.33 indicates Positive momentum. The RSI at 44.40 is Neutral, neither overbought nor oversold. The STOCH value of 15.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:6523.

PHC Holdings Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥16.35B15.693.54%-8.07%-38.21%
73
Outperform
¥32.31B10.572.67%7.99%28.81%
70
Outperform
¥300.00B21.871.78%4.43%-1.39%
63
Neutral
¥76.91B35.042.35%3.80%6.68%
56
Neutral
¥13.48B10.232.93%4.84%-148.94%
54
Neutral
€123.43B10.858.31%4.32%0.70%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6523
PHC Holdings Corp.
968.00
-13.23
-1.35%
JP:4549
Eiken Chemical Co., Ltd.
2,366.00
-34.29
-1.43%
JP:6678
Techno Medica Co., Ltd.
1,922.00
133.08
7.44%
JP:6823
Rion Co., Ltd.
2,622.00
502.79
23.73%
JP:6849
Nihon Kohden Corporation
1,859.00
-215.34
-10.38%
JP:7600
Japan Medical Dynamic Marketing, Inc.
512.00
-175.65
-25.54%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 08, 2025